Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus and EYLEA in Exudative AMD
NCT02732899Phase 2Completed
- Sponsor
- Raj K. Maturi MD
- Start
- Apr 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in exudative age-related macular degeneration, sponsored by Raj K. Maturi MD. Started Apr 2016; status: completed.
02
Drugs
sirolimus
03
Conditions
exudative age-related macular degeneration
Beyond the preview
Go deeper on NCT02732899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02732899.